Journal
FRONTIERS IN PHARMACOLOGY
Volume 8, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2017.00311
Keywords
check point inhibitors; immune related adverse events; nivoulmab; pembrolizumab; ipilimumab
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Recommended
No Data Available
Share Paper
